Skip to content
SHL Telemedicine
  • Home
  • About
    • SHL at a Glance
    • Mission
    • Client Portfolio
    • Partners
    • Leadership Team
  • Solutions & Products
    • Professionals
      • Solutions For CHF
      • Solution for COPD
      • Readmissions Solutions
      • Products
    • Consumers
      • Cardiac Monitoring Service
      • Personal Health Record
    • Telemedicine 24/7
  • Investors
    • Share Information
      • Share Price
      • Shareholder Structure
    • Newsroom
    • SEC Filings / Submissions
    • Annual Reports
      • Annual Reports
      • Key Figures
    • General Meeting
    • Corporate Governance
    • Event Calendar
    • IR Contact
  • Newsroom
  • Contact
  • Toggle website search
Press Escape to close the search panel.
  • Home
  • About
    • SHL at a Glance
    • Mission
    • Client Portfolio
    • Partners
    • Leadership Team
  • Solutions & Products
    • Professionals
      • Solutions For CHF
      • Solution for COPD
      • Readmissions Solutions
      • Products
    • Consumers
      • Cardiac Monitoring Service
      • Personal Health Record
    • Telemedicine 24/7
  • Investors
    • Share Information
      • Share Price
      • Shareholder Structure
    • Newsroom
    • SEC Filings / Submissions
    • Annual Reports
      • Annual Reports
      • Key Figures
    • General Meeting
    • Corporate Governance
    • Event Calendar
    • IR Contact
  • Newsroom
  • Contact
  • Toggle website search
Search this website

SHL announces full-year 2024 results

For more information, please click here

Continue ReadingSHL announces full-year 2024 results
  • Post published:April 24, 2025
  • Post category:

SHL discloses write-offs and extraordinary items for full year results 2024

For more information, please click here

Continue ReadingSHL discloses write-offs and extraordinary items for full year results 2024
  • Post published:April 3, 2025
  • Post category:

SHL acquires remaining stake of Mediton Group

For more information, please click here

Continue ReadingSHL acquires remaining stake of Mediton Group
  • Post published:March 24, 2025
  • Post category:

SHL Telemedicine Ltd. to delist its ADRs from Nasdaq and terminate its U.S. ADR program and SEC reporting obligations

For more information, please click here

Continue ReadingSHL Telemedicine Ltd. to delist its ADRs from Nasdaq and terminate its U.S. ADR program and SEC reporting obligations
  • Post published:March 11, 2025
  • Post category:

SHL appoints Lior Haalman as new CFO

For more information, please click here

Continue ReadingSHL appoints Lior Haalman as new CFO
  • Post published:February 4, 2025
  • Post category:

SHL announces half-year results 2024

For more information, please click here

Continue ReadingSHL announces half-year results 2024
  • Post published:September 26, 2024
  • Post category:

SHL to acquire remaining stake of Mediton

For more information, please click here

Continue ReadingSHL to acquire remaining stake of Mediton
  • Post published:September 24, 2024
  • Post category:

SHL Telemedicine to appoint Dr. Itamar Offer as Chairman of the Company’s Board of Directors

For more information, please click here

Continue ReadingSHL Telemedicine to appoint Dr. Itamar Offer as Chairman of the Company’s Board of Directors
  • Post published:September 3, 2024
  • Post category:

SHL Telemedicine’s Chairman announced he is stepping down

For more information, please click here

Continue ReadingSHL Telemedicine’s Chairman announced he is stepping down
  • Post published:August 26, 2024
  • Post category:
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page

SHL HEADQUARTERS

  • Yigal Alon 90
    Tel Aviv, Israel 67891
  • +972-3-5612212

EUROPE

  • Balanstraße 69 b
    Munich, Germany, 81541
  • +49-89-48059-0

USA

  • 350 Motor Parkway, Suite 204
    Hauppauge, NY 11788
  • +1-877-777-9794

Subscribe for News and Updates


Loading

Accessibility Toolbar

  • Powered with favoriteLove by Codenroll